Filing Details

Accession Number:
0001209191-22-046957
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-19 20:02:10
Reporting Period:
2022-08-17
Accepted Time:
2022-08-19 20:02:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1856725 Rani Therapeutics Holdings Inc. RANI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1865699 Andrew Farquharson C/O Rani Therapeutics Llc
2051 Ringwood Ave.
San Jose CA 95131
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2022-08-17 71,042 $10.51 74,334 No 4 S Indirect See footnote
Class A Common Stock Disposition 2022-08-17 9,210 $11.62 65,124 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The Reporting Person is a General Partner of Rani Investment Corp. Represents Class A Shares held by Rani Investment Corp.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.39 to $11.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (4) to this Form 4.
  3. The Reporting Person is a General Partner of InCube Ventures II, L.P., VH Moll, L.P., and Rani Investment Corp. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 12,343 shares of Class A Common Stock of the Issuer held by VH Moll, L.P., and 9,210 shares of Class A Common Stock of the Issuer held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.39 to $11.975, inclusive.
  5. The Reporting Person is a General Partner of InCube Ventures II, L.P. and VH Moll, L.P. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P. and 12,343 shares of Class A Common Stock of the Issuer held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.